Page 28 - Diagnostics Devices Segment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Diagnostics devices segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Diagnostics Devices Segment Today - Breaking & Trending Today

AI in Diagnostics: Revolution or Evolution? - Indian News |

Discover the impact of artificial intelligence (AI) in diagnostics and medicine. Explore the integration of AI into the diagnostic process, examples of AI in diagnostic procedures, and the future of diagnostic medicine with AI advancements. ....

Shibu Vijayan , Dr Shibu Vijayan , Artificial Intelligence ,

Freenome liberated with $254M infusion for cancer testing

If Freenome Holdings Inc.’s $254 million funding round is a sign, the capital markets for med-tech may finally be thawing. The cancer diagnostics company’s latest cash infusion brings its total funds raised to date to more than $1.3 billion. Freenome co-founder and Chief Product Officer Riley Ennis told BioWorld the company’s success in raising cash in a challenging market was attributable to the “perfect storm of huge unmet need and the opportunity that we have, given the treatment advancements.” ....

Riley Ennis , Freenome Holdings Inc , Freenome Holdings , Chief Product Officer Riley Ennis , Bioworld Medtech , Freenome Inc , Freenome Holdings Inc , Liquid Biopsy , Cancer Screening , Quest Diagnostics Inc , Roche Holding Ag ,

Eight questions you should ask after a cancer diagnosis

It can be difficult to talk about cancer but unfortunately rates of most cancers are on the rise with 1 in 2 of us developing cancer in our lifetime and it’s. ....

United Kingdom , Two Week Wait ,

Acorai raises $4.5M in seed for heart monitor trial

The $4.5 million in seed funding that Acorai AB recently raised will allow the company to continue its forward momentum in developing its technology to support the treatment of patients living with heart failure, Matthew Mace, co-founder and chief scientific officer told BioWorld. In practice, this means that with the funds the company will be able to meet its “projected timelines on the path toward regulatory approval in the U.S., focus on market entry and get the device into the hands of health care professionals sooner.” ....

Matthew Mace , Bioworld Medtech , Acorai Ab , Heart Failure , Seed Round , Heart Monitor , Capture Hf Study ,